摘要 |
The invention relates to biologically active molecules, interacting with thrombin and inhibiting the same. The invention particularly relates to molecules of general formula:Y<SUP>1</SUP>-(NH-X<SUP>1</SUP>-C-O)-(NH-X<SUP>2</SUP>-C-C)-(NH-X<SUP>3</SUP>-C-O)NH-X<SUP>4</SUP>-C-O)-(NH-X<SUP>5</SUP>-C-O)-(NH-X<SUP>6</SUP>-C-O)-Y<SUP>2</SUP>, in which Y<SUP>1</SUP>, Y<SUP>2</SUP>, and X<SUP>1-6 </SUP>have the meanings given in the description, N or C-terminal shortened variants of said compounds and the use thereof for the production of medicaments.
|